1. Home
  2. BAFN vs ICCC Comparison

BAFN vs ICCC Comparison

Compare BAFN & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

HOLD

Current Price

$7.92

Market Cap

40.6M

Sector

Finance

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$5.49

Market Cap

55.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAFN
ICCC
Founded
1999
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
55.5M
IPO Year
N/A
1987

Fundamental Metrics

Financial Performance
Metric
BAFN
ICCC
Price
$7.92
$5.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.1K
18.5K
Earning Date
10-30-2025
11-13-2025
Dividend Yield
2.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$58,931,000.00
$27,769,304.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$20.34
Revenue Growth
N/A
16.49
52 Week Low
$6.40
$4.19
52 Week High
$19.75
$7.60

Technical Indicators

Market Signals
Indicator
BAFN
ICCC
Relative Strength Index (RSI) 36.45 46.52
Support Level $8.05 $4.72
Resistance Level $8.07 $5.36
Average True Range (ATR) 0.11 0.32
MACD 0.04 0.06
Stochastic Oscillator 22.22 63.12

Price Performance

Historical Comparison
BAFN
ICCC

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: